Greenwich LifeSciences
GLSI
#8929
Rank
โ‚ฌ0.18 B
Marketcap
12,50ย โ‚ฌ
Share price
-7.86%
Change (1 day)
76.61%
Change (1 year)

Greenwich LifeSciences (GLSI) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : โ‚ฌ5.23 Million

According to Greenwich LifeSciences's latest financial reports the company's total liabilities are โ‚ฌ5.23 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Greenwich LifeSciences - Total liabilities on balance sheet (from 2019 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚ฌ0.24 M-27.94%
2021-12-31โ‚ฌ0.34 M-59.99%
2020-12-31โ‚ฌ0.85 M-30.85%
2019-12-31โ‚ฌ1.22 M-86.25%
2018-12-31โ‚ฌ8.94 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Organovo
ONVO
โ‚ฌ3.77 M-27.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
โ‚ฌ0.11 B 2,018.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
โ‚ฌ1.04 B 19,802.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
โ‚ฌ0.41 B 7,836.57% Jersey